In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks
- PMID: 28505637
- DOI: 10.7326/ACPJC-2017-166-10-053
In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks
Comment on
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical